Literature DB >> 12762958

New technologies and therapeutic approaches for the management of pediatric diabetes.

M T Lawlor1, L M Laffel.   

Abstract

Evolving trends in technology and therapeutic strategies create a very exciting time for the management of diabetes. Technology, like the internet, helps us to keep up with this fast-paced, changing world of diabetes. New therapies most often begin with adult clinical trials; once safety and efficacy are demonstrated, practice recommendations follow for the pediatric population. The Diabetes Research Working Group has defined potentially important new directions and technologies for diabetes research. The group has recommended the creation of regional centers of technologic excellence, if contemporary diabetes research is to succeed. An overview of recent advances in diabetes technology follows covering five main areas: monitoring, telemedicine, insulin analogues, insulin delivery devices, and islet cell transplantation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12762958     DOI: 10.1007/s11892-001-0011-0

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  32 in total

1.  Use of insulin pump therapy at nighttime only for children 7-10 years of age with type 1 diabetes.

Authors:  F R Kaufman; M Halvorson; C Kim; P Pitukcheewanont
Journal:  Diabetes Care       Date:  2000-05       Impact factor: 19.112

2.  Time-action profile of the long-acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo.

Authors:  L Heinemann; R Linkeschova; K Rave; B Hompesch; M Sedlak; T Heise
Journal:  Diabetes Care       Date:  2000-05       Impact factor: 19.112

3.  A 16-week comparison of the novel insulin analog insulin glargine (HOE 901) and NPH human insulin used with insulin lispro in patients with type 1 diabetes.

Authors:  P Raskin; L Klaff; R Bergenstal; J P Hallé; D Donley; T Mecca
Journal:  Diabetes Care       Date:  2000-11       Impact factor: 19.112

4.  Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets.

Authors:  N Lumelsky; O Blondel; P Laeng; I Velasco; R Ravin; R McKay
Journal:  Science       Date:  2001-04-26       Impact factor: 47.728

5.  Continuous subcutaneous glucose monitoring in children with type 1 diabetes.

Authors:  H P Chase; L M Kim; S L Owen; T A MacKenzie; G J Klingensmith; R Murtfeldt; S K Garg
Journal:  Pediatrics       Date:  2001-02       Impact factor: 7.124

6.  Use of an automated device for alternative site blood glucose monitoring.

Authors:  S E Fineberg; R M Bergenstal; R M Bernstein; L M Laffel; S L Schwartz
Journal:  Diabetes Care       Date:  2001-07       Impact factor: 19.112

7.  In vitro cultivation of human islets from expanded ductal tissue.

Authors:  S Bonner-Weir; M Taneja; G C Weir; K Tatarkiewicz; K H Song; A Sharma; J J O'Neil
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

8.  Correlation of fingerstick blood glucose measurements with GlucoWatch biographer glucose results in young subjects with type 1 diabetes.

Authors:  S K Garg; R O Potts; N R Ackerman; S J Fermi; J A Tamada; H P Chase
Journal:  Diabetes Care       Date:  1999-10       Impact factor: 19.112

9.  Inhaled human insulin treatment in patients with type 2 diabetes mellitus.

Authors:  W T Cefalu; J S Skyler; I A Kourides; W H Landschulz; C C Balagtas; S Cheng; R A Gelfand
Journal:  Ann Intern Med       Date:  2001-02-06       Impact factor: 25.391

10.  Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol.

Authors:  E A Ryan; J R Lakey; R V Rajotte; G S Korbutt; T Kin; S Imes; A Rabinovitch; J F Elliott; D Bigam; N M Kneteman; G L Warnock; I Larsen; A M Shapiro
Journal:  Diabetes       Date:  2001-04       Impact factor: 9.461

View more
  1 in total

1.  The Evolving Role of Short-Term Professional Continuous Glucose Monitoring on Glycemic Control and Hypoglycemia Among Saudi Patients with Type 1 Diabetes: A Prospective Study.

Authors:  Ayman A Al Hayek; Asirvatham A Robert; Mohammed Al Dawish; Rania A Ahmed; Fahad S Al Sabaan
Journal:  Diabetes Ther       Date:  2015-07-05       Impact factor: 2.945

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.